USP37 and cancer: Next, we analyzed the cell proliferation in these cells with or without cisplatin treatment and found reconstituted with USP37 WT but not S114A (phosphorylation-deficient) mutant led cancer cell resistant to cisplatin treatment in vitro (Supplementary Figure S6L).